Covalab
- Biotech or pharma, therapeutic R&D
- CMO, CRO
Since 1995, Covalab is a pioneering biotechnology company specializing in the development and production of innovative immunotechnology solutions. With a strong focus on research and development, Covalab offers a comprehensive range of high-quality antibodies, proteins, and assay kits designed to meet the diverse needs of the scientific community. Our expertise in antibody engineering and custom services enables us to provide tailored solutions for academic, clinical, and industrial applications. Committed to excellence and innovation, Covalab collaborates with leading researchers and institutions worldwide to advance biomedical research and improve patient outcomes. Our state-of-the-art facilities and dedicated team of scientists ensure the highest standards of quality and reliability in every product we deliver. At Covalab, we are driven by a passion for discovery and a commitment to making a meaningful impact in the field of life sciences.